PTT GLBL CHEM.-NVDR- BA10 (F:GCB1) — Stock Price
PTT GLBL CHEM.-NVDR- BA10 (F:GCB1) is currently trading at €1.25 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.50 and €1.29. This page tracks PTT GLBL CHEM.-NVDR- BA10's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see PTT GLBL CHEM.-NVDR- BA10 (GCB1) cash flow conversion.
PTT GLBL CHEM.-NVDR- BA10 (GCB1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PTT GLBL CHEM.-NVDR- BA10's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
PTT GLBL CHEM.-NVDR- BA10 Income Statement — Revenue, Profit & Earnings by Year
PTT GLBL CHEM.-NVDR- BA10's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €487.58 Billion | €608.55 Billion | €621.63 Billion | €683.95 Billion |
| Cost of Revenue | €466.14 Billion | €575.94 Billion | €584.37 Billion | €631.68 Billion |
| Gross Profit | €21.45 Billion | €32.61 Billion | €37.26 Billion | €52.27 Billion |
| Research & Development | — | — | — | — |
| SG&A | €32.18 Billion | €40.67 Billion | €34.04 Billion | €37.25 Billion |
| Total Operating Expenses | €496.04 Billion | €612.67 Billion | €612.68 Billion | €665.99 Billion |
| Operating Income | €-8.45 Billion | €-4.12 Billion | €8.95 Billion | €17.96 Billion |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €8.80 Billion | €12.16 Billion | €11.72 Billion | €9.84 Billion |
| Income Before Tax | €-15.00 Billion | €-31.18 Billion | €2.22 Billion | €-9.91 Billion |
| Income Tax Expense | — | — | — | — |
| Net Income | €-14.60 Billion | €-29.81 Billion | €999.13 Million | €-8.75 Billion |
PTT GLBL CHEM.-NVDR- BA10 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PTT GLBL CHEM.-NVDR- BA10's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €606.37 Billion | €645.84 Billion | €719.00 Billion | €719.97 Billion |
| Total Current Assets | €135.25 Billion | €156.13 Billion | €186.87 Billion | €172.01 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €207.00 Million | €353.00 Million | €8.93 Billion | €6.02 Billion |
| Net Receivables | €39.41 Billion | €47.75 Billion | €57.76 Billion | €45.25 Billion |
| Inventory | €59.06 Billion | €65.22 Billion | €68.52 Billion | €76.62 Billion |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €74.39 Billion | €71.02 Billion | €76.09 Billion | €73.75 Billion |
| Total Liabilities | €310.60 Billion | €377.25 Billion | €422.82 Billion | €421.14 Billion |
| Total Current Liabilities | €113.94 Billion | €114.13 Billion | €125.84 Billion | €103.98 Billion |
| Long-term Debt | €143.02 Billion | €207.11 Billion | €243.93 Billion | €263.89 Billion |
| Net Debt | €134.67 Billion | €196.44 Billion | €227.73 Billion | €251.61 Billion |
| Total Stockholder Equity | €289.94 Billion | €261.63 Billion | €288.89 Billion | €291.30 Billion |
| Retained Earnings | €143.37 Billion | €161.36 Billion | €194.88 Billion | €194.81 Billion |
PTT GLBL CHEM.-NVDR- BA10 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PTT GLBL CHEM.-NVDR- BA10 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €40.83 Billion | €32.32 Billion | €48.23 Billion | €-3.43 Billion |
| Capital Expenditures | €14.03 Billion | €15.83 Billion | €19.59 Billion | €21.37 Billion |
| Free Cash Flow | €26.81 Billion | €16.49 Billion | €28.65 Billion | €-24.80 Billion |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | €-41.84 Billion | €-33.74 Billion | €-25.12 Billion | €-14.16 Billion |
| Dividends Paid | €2.52 Billion | €3.50 Billion | €1.27 Billion | €11.75 Billion |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €26.38 Billion | €29.48 Billion | €28.49 Billion | €27.56 Billion |
| Change in Cash | €-13.82 Billion | €-4.57 Billion | €11.38 Billion | €-29.67 Billion |
PTT GLBL CHEM.-NVDR- BA10 Earnings History — EPS Actual vs. Analyst Estimates
Track PTT GLBL CHEM.-NVDR- BA10's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Feb 16, 2026 | — | — | — |
| Nov 04, 2025 | — | — | — |
| Aug 06, 2025 | — | — | — |
| May 12, 2025 | — | — | — |
| Feb 10, 2025 | — | — | — |
| Nov 06, 2024 | — | — | — |